CervoMed Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About CRVO
CervoMed Inc. is a clinical-stage company focused on developing treatments for age-related neurologic disorders. The Company is developing neflamapimod, an investigational, orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in Lewy bodies (DLB) and certain other neurological disorders. It focuses on reducing the impact of inflammation in the brain, or neuroinflammation, which is a key factor in the manifestation of degenerative diseases of the brain, including DLB. Neflamapimod is being evaluated in the Company's ongoing RewinD-LB Trial, a Phase 2b trial in patients with DLB.
Find out what a historical investment in CervoMed Inc would be worth today using our CRVO stock calculator.
$77.26M
-
0.00%
50.7K
$8.35
$7.61
$8.31
$16.94
$1.80
Ready to start your investing journey with Stake?
Open an accountCRVO FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CRVO
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CRVO
on Stake
Buy CRVO from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of CRVO from only US$10 with fractional shares
